AMERIPRISE FINANCIAL INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2020$134,000
-54.4%
34,495
-52.7%
0.00%
Q3 2020$294,000
+20.0%
72,965
+25.7%
0.00%
Q2 2020$245,000
-79.9%
58,028
+32.3%
0.00%
-100.0%
Q3 2015$1,219,00043,8730.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders